Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Lilly fends off Cialis generics with new patent settlement
Fierce Pharma
Thu, 07/13/17 - 05:31 pm
Tags:
Eli Lilly, Cialis, generics, patents, erectile dysfunction
5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings
Yahoo/Zacks.com
Thu, 07/13/17 - 09:49 am
Tags:
earnings, Merck, Eli Lilly, Celgene, Gilead Sciences, Shire
Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod
Fierce Pharma
Tue, 07/11/17 - 09:56 am
Tags:
Eli Lilly, Pfizer, Novartis, breast cancer, abemaciclib, Ibrance, Kisqali
Why Drugmakers Aren’t Sweating the Next Wave of Patent Losses
Bloomberg
Sat, 07/8/17 - 10:18 am
Tags:
patents, Roche, Sanofi, Eli Lilly, patent cliff
Eli Lilly Wins Cancer Drug Patent Case at U.K. Supreme Court
Bloomberg
Fri, 07/7/17 - 10:01 am
Tags:
Eli Lilly, patents, UK, Altima, Actavis, Allergan, Teva Pharmaceutical
Eli Lilly pledges up to $52m to Purdue for improving injection tech
Drug Delivery Business News
Thu, 07/6/17 - 02:39 pm
Tags:
Eli Lilly, Purdue Univeristy, drug delivery
Lilly’s Olumiant, spurned by FDA, gets nod from NICE
Fierce Pharma
Sat, 07/1/17 - 09:26 am
Tags:
FDA, NICE, Europe, Eli Lilly, olumiant, rheumatoid arthritis, Humira
BI, Lilly hit the streets to talk up Jardiance's cardiovascular benefits
Fierce Pharma
Wed, 06/28/17 - 10:13 am
Tags:
Boehringer Ingelheim, Eli Lilly, Jardiance, drug ads, DTC advertising
Little Alder bags positive PhIII migraine data, but giant rivals are racing ahead in a crowded field
Endpoints
Tue, 06/27/17 - 09:38 am
Tags:
Alder Biopharma, migraines, clinical trials, eptinezumab, Eli Lilly, Amgen, Novartis, Merck
Eli Lilly completes expansion of San Diego biotech center
Fierce Biotech
Fri, 06/23/17 - 09:44 am
Tags:
Eli Lilly, San Diego, biotech
For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive
Medical Marketing and Media
Thu, 06/22/17 - 09:32 am
Tags:
diabetes, blood sugar, competition, Novo Nordisk, Victoza, Eli Lilly, Jardiance, Invokana, JNJ
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?
Xconomy
Wed, 06/21/17 - 09:46 am
Tags:
Alzheimer's disease, anti-amyloid, solanezumab, Eli Lilly, Biogen, aducanumab, RVT-101
Eli Lilly CEO David Ricks weighs in on drug costs and health reform
CNBC
Sat, 06/17/17 - 07:25 pm
Tags:
Eli Lilly, David Ricks, Pharma CEOs, healthcare reform, drug pricing
5 Things You Didn't Know About Eli Lilly and Co
Motley Fool
Thu, 06/15/17 - 09:47 am
Tags:
Eli Lilly, drug pricing, M&A, animal health
Lilly wins FDA nod for Humalog pre-filled Junior KwikPen device
Drug Delivery Business News
Wed, 06/14/17 - 09:05 pm
Tags:
Eli Lilly, FDA, Humalog, devices, diabetes, Junior KwikPen
J&J's Invokana lowers CV risk, but by enough to compete?
BioPharma Dive
Wed, 06/14/17 - 11:37 am
Tags:
JNJ, Invokana, diabetes, Jardiance, Eli Lilly, Boehringer Ingelheim
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
BioPharma Dive
Tue, 06/13/17 - 12:15 pm
Tags:
diabetes, Merck, Pfizer, SGLT2 inhibitor, Januvia, Invokana, Farxiga, Jardiance, Eli Lilly, Boehringer Ingelheim, AstraZeneca, JNJ
Eli Lilly posts promising PhIII migraine results, but settles into the pack in the last leg of the race to the FDA
Endpoints
Sun, 06/11/17 - 04:58 pm
Tags:
Eli Lilly, migraines, galcanezumab
ADA preview: 5 things to watch in diabetes
BioPharma Dive
Sun, 06/11/17 - 09:30 am
Tags:
ADA, diabetes, Jardiance, Eli Lilly, Boehringer Ingelheim, Lantus, Tresiba, JNJ, Novo Nordisk, PCSK9 inhibitors, Amgen Regeneron, Sanofi, Apple, Google, insulin
Lilly preps galcanezumab for 2017 filing
BioPharma Dive
Sun, 06/11/17 - 09:15 am
Tags:
Eli Lilly, galcanezumab, migraines, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.